Brief: Oncosil Medical Posts Loss For Year Attributable A$11.3 Mln
31/08/2023 09:20
Aug 31 (Reuters) - Oncosil Medical Ltd OSL.AX :
* LOSS FOR YEAR ATTRIBUTABLE A$11.3 MILLION
Source text for Eikon: ID:nASX8G22v0
Further company coverage: OSL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncosil Medical
See all newsAustralia's OncoSil Medical gains most in over 2 months on reaching 100-th patient milestone
Brief: Oncosil Medical Says FDA Grants Hde Approval For Oncosil Device For Distal Cholangiocarcinoma
Brief: Oncosil Medical Posts FY26 Unit Sales Up 53%, Revenue Up 44% Versus FY25
Brief: Oncosil Medical Receives Saudi FDA Approval
Brief: Oncosil Medical Files For FDA Approval